Waregem (Belgium) / Rotterdam (The Netherlands)[1], 15 May 2012 – The Annual General Meeting of Shareholders, held on 14 May 2012, has approved all motions put forward by the Board of Directors of Arseus.
The shareholders adopted, amongst other things, the annual accounts 2011 and determined the dividend over 2011 at € 0.50 per share. The shareholders granted full discharge to the directors and the statutory auditor who were active during the financial year 2011.
The gross dividend paid out by Arseus (coupon number 5) will amount to € 0.50 per share. The net dividend will amount to € 0.375 per share, being gross dividend less 25% Belgian dividend withholding tax. Any shares accompanied by a VVPR-strip (coupon number 5) will be subject to a Belgian withholding tax of 21%, so a net dividend of € 0.395 per share will be paid on those shares. However, an additional tax of 4% is foreseen on interests and dividends (on stocks with VVPR strips) amounting to more than € 20,020 per Belgian resident individual.
The timetable is as follows:
16 May Ex-dividend quotation
18 May Record date
21 May Dividend payable
As the Extraordinary Shareholders’ Meeting did not meet the required legal quorum, a second Extraordinary Shareholders’ Meeting will be held on Tuesday 5 June 2012 at 15.00 p.m., at the company’s statutory office (Textielstraat 24, 8790 Waregem). The convocation for this Meeting will be published on 18 May 2012.
In the event of any discrepancy between the English translation and the original Dutch version of this press release, the latter shall prevail.
[1] This press release was sent out by Arseus NV and Arseus BV.
For more information:
Constantijn van Rietschoten
Director of Corporate Communications
+31 88 33 11 222 (office)
+31 6 536 91 585 (mobile)
constantijn.van.rietschoten@arseus.com
Arseus Profile
Arseus is a multinational group of companies that supplies products, services and concepts to professionals and institutions in the healthcare sector in Europe, the US, Brazil and Argentina. Arseus is subdivided into four divisions and operates in the markets for pharmaceutical compounding for pharmacies, dental products, medical and surgical products, and medical ICT-solutions. The Belgian company Arseus NV is located in Waregem, and is listed on NYSE Euronext Brussels and NYSE Euronext Amsterdam. The operational activities of the Arseus group are driven by the Dutch company Arseus BV. The head office of Arseus BV is located in Rotterdam.
Please open the link below for the full press release: